Navigation Links
Federal Lawsuits Involving Defective Hip Replacement Parts Consolidated In Ohio

MONTGOMERY, Ala., Dec. 6, 2010 /PRNewswire/ -- It was announced this weekend that federal cases involving defective hip implant parts manufactured by DePuy Orthopaedics, a subsidiary of Johnson & Johnson, will be consolidated in federal court in the Northern District of Ohio under U.S. District Judge David A. Katz. The hip implant parts were recalled August 26 after research indicated patients who received the parts required a much higher than usual rate of revision surgeries. The recall affects 93,000 people and it is expected that thousands of lawsuits will be filed on behalf of people injured by the defective parts.

"As expected the Multi-district litigation (MDL) judicial panel selected Judge David A. Katz in the Northern District of Ohio to oversee all federal court cases involving the DePuy hip implant recall. Since counsel for several plaintiffs, along with counsel for DePuy and Johnson & Johnson specifically requested Judge Katz to preside over this litigation, I think that he was a good choice for the DePuy MDL," said Beasley Allen Shareholder Navan Ward, who is investigating hundreds of cases on behalf of clients injured by the defective hip implant. "Based on Judge Katz's experience with other MDLs, we expect that he will do a good job of pushing these cases along, whether it be by settlement or trial. Any existing cases filed in various federal courts around the country will likely soon be transferred to his court in order to begin litigation in his court," Ward said.

Consolidating cases into a multidistrict litigation (MDL) allows the committee overseeing the process to focus on moving the case forward in a consistent way. Lawyers will coordinate the litigation and work together on issues of discovery. A similar process was instituted in the BP Oil Spill litigation, with thousands of cases consolidated in New Orleans under U.S. District Judge Carl Barbier. Beasley Allen attorney Rhon Jones is serving on the Plaintiffs Steering Committee (PSC) for that MDL.

The recall involves the ASR XL Acetabular and ASR Resurfacing systems. Patients who received the defective hip replacement parts from DePuy may experience symptoms including pain, swelling and trouble walking. These symptoms may indicate serious problems such as the hip implant loosening from the bone, fracturing the bone to which it is attached, or dislocating. However, even people who are not currently experiencing symptoms may be at risk. The recalled part uses metal-on-metal parts to reduce wear. However, the friction between these parts may release particles of toxic heavy metals into the tissue and bloodstream, causing metal poisoning. This can result in serious injury, including tumors, neurological problems and heart failure.

About Beasley Allen Law FirmHeadquartered in Montgomery, Alabama, Beasley Allen is comprised of 50 attorneys and more than 200 support staff. Beasley Allen is a national leader in civil litigation, with verdicts and settlements of over $21 billion. For more information about our firm, please visit our website at Media Contact:Helen Taylor(334) 495-1169(334) 201-2311 cell(800) 898-2034

SOURCE Beasley Allen Law Firm
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. States, Federal Government Could Save $30 Billion by Managing Medicaid Pharmacy More Like Medicare and Commercial Sector Programs
2. Epeius Biotechnologies Awarded Federal Grant Advancing Tumor-Targeted Cancer Therapy
3. GeoVax Awarded Federal Grant Under the Qualifying Therapeutic Discovery Project Program
4. Cardiogenesis Receives Research Award From Federal Government
5. Indiana Life Sciences Start Ups Garner More than $1.5 Million in Competitive Federal Funding
6. Federal Panel Grants Lanier Law Firm Motion for Hearing on National Coordination of DePuy Hip Implant Lawsuits
7. Parents Bring Federal Lawsuit After Tainted Baby Formula Injures Newborn
8. Federal Government Selects Thomson Reuters to Build Tool That Streamlines Comparative Effectiveness Research
9. Ziehm Imaging Provides Germanys Federal Armed Forces (Bundeswehr) With Mobile X-Ray Systems
10. NeoStem Comments on Recent Court Ruling Blocking the Federal Governments Funding of Embryonic Stem Cell Research
11. Pfenex Inc. Awarded Contract With the United States Federal Government Potentially Totaling Up to $18.8 Million to Develop a Robust Pfenex Expression Technology Based Process for the Production of Bulk Recombinant Protective Antigen (rPA) From Anthr
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... "Self Administration of High Viscosity Drugs" ... ) has announced the addition of the ... to their offering. --> Research and ... of the "Self Administration of High Viscosity ...
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... announced the addition of the  "2016 ... the European Cell Surface Marker Testing ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
(Date:11/25/2015)... 25, 2015  Amgen (NASDAQ: AMGN ) today ... with the United States (U.S.) ... biosimilar candidate to Humira ® (adalimumab). Amgen believes ... to the FDA and represents Amgen,s first BLA submission ... Harper , M.D., executive vice president of Research and ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... ... convenient way to dispense prescription medications at home, so he invented the patent-pending ... monitor and dispense prescription medications. In doing so, it could help to prevent ...
(Date:11/27/2015)... ... 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% ... More than 3.7 billion people under the age of 50 – or 67% of the ... first global estimates of HSV-1 infection . , "The data shocks us highly!" said ...
(Date:11/27/2015)... ... November 27, 2015 , ... Keeping in mind challenges ... health and wellness consultation, has collaborated with a leading web-based marketplace for extra-curricular ... experienced by parents and bring advice from parenting experts within their reach. As ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft ... announces the incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite ... LTS brings Q-Suite 5.10 up-to-date with a version of Asterisk that will receive ...
(Date:11/26/2015)... ... 2015 , ... The Catalent Applied Drug Delivery Institute today ... dose form selection in early phase drug development. The first of these is ... together the UK’s emerging life sciences companies, corporate partners, and investors, at Milton ...
Breaking Medicine News(10 mins):